HWKN HAWKINS INC
Wholesale-Chemicals & Allied Products · Nasdaq · SEC CIK 46250 · Fiscal year ends 03/28
Financial factors as of 2026-09-27 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.0%
TTM net income YoY3.2%
TTM EPS YoY3.8%
Revenue 3-yr CAGR6.8%
Net income 3-yr CAGR7.5%
Margins
Gross margin22.4%
Operating margin11.1%
Net margin7.5%
FCF margin8.1%
EBITDA margin16.0%
Returns
ROE16.0%
ROA8.6%
ROIC (approx.)12.8%
Asset turnover1.14x
Leverage & solvency
Liabilities / assets44.3%
Debt / equity0.41x
Current ratio2.28x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.73x
Accruals ratio-6.3%
Payout ratio18.7%
Capex / revenue4.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-09-27 | 2026Q12026-06-28 | 2026Q4*2026-03-29 | 2026Q32025-12-28 | 2026Q22025-09-28 | 2025Q12025-06-29 | 2025Q4*2025-03-30 | 2025Q32024-12-29 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $313.82M | $315.68M | $265.91M | $244.08M | $280.43M | $293.27M | $245.32M | $226.21M |
| Cost of revenue | $237.21M | $241.67M | $211.67M | $193.27M | $212.79M | $220.91M | $193.08M | $177.78M |
| Gross profit | $76.61M | $74.01M | $54.24M | $50.81M | $67.64M | $72.36M | $52.24M | $48.42M |
| SG&A expense | $34.70M | $35.34M | $30.77M | $28.26M | $33.70M | $31.03M | $27.66M | $27.36M |
| Operating income | $41.91M | $38.67M | $23.46M | $22.56M | $33.94M | $41.33M | $24.57M | $21.06M |
| Income tax | $11.75M | $9.07M | $4.46M | $5.27M | $8.23M | $9.83M | $6.09M | $5.26M |
| Net income | $27.78M | $28.25M | $15.46M | $14.31M | $22.60M | $29.18M | $16.33M | $15.02M |
| EBITDA | $56.20M | $52.62M | $37.04M | $35.97M | $47.20M | $53.62M | $35.16M | $31.17M |
| EPS (basic) | 1.34 | 1.36 | — | 0.69 | 1.09 | 1.41 | — | 0.72 |
| EPS (diluted) | 1.34 | 1.35 | — | 0.69 | 1.08 | 1.40 | — | 0.72 |
| Dividends declared per share | 0.20 | 0.19 | 0.19 | 0.19 | 0.19 | 0.18 | 0.18 | 0.18 |
| Weighted avg. shares (diluted) | 20.78M | 20.85M | — | 20.84M | 20.85M | 20.81M | — | 20.88M |
| Banking | ||||||||
| Net interest income | -$2.64M | -$2.77M | -$2.97M | -$3.43M | -$3.83M | -$3.27M | -$1.53M | -$1.22M |
| Balance sheet | ||||||||
| Cash & equivalents | $7.10M | $7.98M | $3.91M | $8.21M | $10.41M | $14.50M | $5.10M | $8.30M |
| Receivables | $149.28M | $151.77M | $139.80M | $123.74M | $131.09M | $140.11M | $131.79M | $111.52M |
| Inventory | $92.95M | $79.86M | $78.20M | $85.93M | $92.91M | $95.72M | $83.51M | $81.63M |
| Current assets | $257.12M | $248.78M | $231.47M | $228.20M | $239.56M | $256.42M | $230.69M | $210.35M |
| PP&E, net | $271.75M | $270.59M | $266.26M | $252.98M | $247.44M | $243.38M | $225.29M | $220.44M |
| Goodwill | $224.44M | $223.83M | $223.04M | $223.03M | $222.15M | $218.90M | $135.41M | $116.74M |
| Intangibles | $224.46M | $229.02M | $232.89M | $238.38M | $241.08M | $239.97M | $150.12M | $130.47M |
| Total assets | $1.01B | $1.01B | $986.29M | $976.53M | $984.16M | $988.27M | $770.05M | $707.24M |
| Current liabilities | $112.76M | $109.61M | $104.84M | $97.16M | $98.56M | $110.93M | $97.22M | $84.25M |
| Short-term debt | — | — | — | $9.81M | $9.81M | $9.81M | $9.91M | $9.91M |
| Long-term debt | $229.00M | $244.00M | $244.00M | $253.38M | $268.33M | $288.28M | $149.00M | $103.88M |
| Total debt | $229.00M | $244.00M | $244.00M | $263.19M | $278.14M | $298.09M | $158.91M | $113.80M |
| Total liabilities | $448.36M | $458.04M | $452.28M | $457.62M | $477.20M | $503.70M | $309.76M | $250.26M |
| Shareholders' equity | $563.69M | $548.20M | $534.01M | $518.91M | $506.97M | $484.57M | $460.29M | $456.98M |
| Net debt | $221.90M | $236.02M | $240.09M | $254.98M | $267.73M | $283.59M | $153.81M | $105.49M |
| Shares outstanding | 20.67M | 20.74M | 20.75M | 20.74M | 20.74M | 20.72M | 20.68M | 20.77M |
| Cash flow statement | ||||||||
| Operating cash flow | $40.34M | $35.15M | $37.73M | $35.56M | $39.54M | $31.49M | $30.84M | $21.04M |
| Capital expenditure | $10.75M | $11.61M | $19.58M | $14.32M | $10.80M | $13.54M | $11.09M | $8.72M |
| Free cash flow | $29.59M | $23.55M | $18.16M | $21.24M | $28.74M | $17.95M | $19.76M | $12.31M |
| Investing cash flow | -$12.09M | -$14.95M | -$19.49M | -$18.80M | -$21.27M | -$164.54M | -$55.13M | -$26.49M |
| Financing cash flow | -$29.12M | -$16.14M | -$22.54M | -$18.97M | -$22.36M | $142.45M | $21.08M | $6.24M |
| Depreciation & amortization | $14.29M | $13.95M | $13.58M | $13.41M | $13.26M | $12.29M | $10.58M | $10.11M |
| Stock-based compensation | $1.93M | $2.23M | $2.13M | $1.85M | $2.38M | $2.21M | $1.48M | $1.72M |
| Dividends paid | $4.17M | $3.97M | $3.97M | $3.97M | $3.97M | $3.75M | $3.75M | $3.76M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.